Exicure, Inc.
E166837
Exicure, Inc. is a biotechnology company specializing in nucleic acid therapeutics based on spherical nucleic acid (SNA) technology.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Exicure, Inc. canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T1468822 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Exicure, Inc. Context triple: [Chad Mirkin, founded, Exicure, Inc.]
-
A.
Zyvex
Zyvex is a pioneering nanotechnology company known for its early work in molecular nanotechnology and advanced manufacturing.
-
B.
Flying J Inc.
Flying J Inc. was a major American truck stop and travel center chain that later became part of the Pilot Flying J network.
-
C.
Ornex
Ornex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
D.
Onex
Onex is a suburban municipality in western Switzerland located just outside the city of Geneva.
-
E.
ITG Brands
ITG Brands is a major U.S. tobacco company known for manufacturing and marketing a portfolio of cigarette and cigar brands that compete with other leading tobacco firms.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Exicure, Inc. Target entity description: Exicure, Inc. is a biotechnology company specializing in nucleic acid therapeutics based on spherical nucleic acid (SNA) technology.
-
A.
Zyvex
Zyvex is a pioneering nanotechnology company known for its early work in molecular nanotechnology and advanced manufacturing.
-
B.
Flying J Inc.
Flying J Inc. was a major American truck stop and travel center chain that later became part of the Pilot Flying J network.
-
C.
Ornex
Ornex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
D.
Onex
Onex is a suburban municipality in western Switzerland located just outside the city of Geneva.
-
E.
ITG Brands
ITG Brands is a major U.S. tobacco company known for manufacturing and marketing a portfolio of cigarette and cigar brands that compete with other leading tobacco firms.
- F. None of above. chosen
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| abbreviation | Exicure ⓘ |
| aimsToTreat |
cancer
ⓘ
genetic diseases ⓘ neurological diseases ⓘ |
| basedOnResearchOf | Chad A. Mirkin ⓘ |
| businessModel |
partnering and collaboration strategy
ⓘ
research and development focused ⓘ |
| coreTechnology |
nanoparticle-based nucleic acids
ⓘ
spherical nucleic acids ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| develops |
antisense therapies
ⓘ
gene regulation therapies ⓘ oligonucleotide therapeutics ⓘ |
| focusesOn |
genetic disorders
ⓘ
immuno-oncology ⓘ neurology ⓘ |
| foundedBy | Chad A. Mirkin ⓘ |
| hasCollaborationWith |
Allergan (prior to its acquisition by AbbVie)
ⓘ
linked to:
Allergan
Ipsen ⓘ |
| headquartersLocation |
Chicago metropolitan area
ⓘ
Skokie, Illinois ⓘ |
| industry | biotechnology ⓘ |
| listedOn | NASDAQ ⓘ |
| pipelineIncludes |
clinical-stage nucleic acid candidates
ⓘ
preclinical nucleic acid candidates ⓘ |
| regulatoryStatus | subject to U.S. FDA regulation ⓘ |
| scientificBasis |
nanotechnology
ⓘ
nucleic acid chemistry ⓘ |
| SNAApplications |
systemic delivery of nucleic acids
ⓘ
topical delivery of nucleic acids ⓘ |
| SNAProperties |
enhanced cellular uptake
ⓘ
improved tissue penetration ⓘ potential for reduced immunogenicity ⓘ |
| specializesIn | nucleic acid therapeutics ⓘ |
| technology | spherical nucleic acid technology ⓘ |
| tickerSymbol | XCUR ⓘ |
| usesPlatform | spherical nucleic acid (SNA) platform ⓘ |
| website | https://www.exicuretx.com/ ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Exicure, Inc. Description of subject: Exicure, Inc. is a biotechnology company specializing in nucleic acid therapeutics based on spherical nucleic acid (SNA) technology.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.